微电生理
(688351)
| 流通市值：123.44亿 | | | 总市值：123.44亿 |
| 流通股本：4.71亿 | | | 总股本：4.71亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 125,927,267.47 | 464,531,979.47 | 336,400,837.87 | 223,748,530.83 |
| 营业收入 | 125,927,267.47 | 464,531,979.47 | 336,400,837.87 | 223,748,530.83 |
| 二、营业总成本 | 121,957,741.76 | 436,363,192.99 | 308,654,820.49 | 201,859,987.04 |
| 营业成本 | 55,664,256.8 | 195,221,050.33 | 137,611,777.99 | 89,276,207.09 |
| 税金及附加 | 1,282,977.72 | 3,526,846.15 | 2,846,155.77 | 2,148,395.43 |
| 销售费用 | 34,711,508.26 | 133,219,020.2 | 95,311,346.03 | 62,936,011.57 |
| 管理费用 | 9,414,188.84 | 43,276,172.53 | 31,323,786.18 | 20,753,359.94 |
| 研发费用 | 17,844,474.09 | 64,081,885.07 | 45,759,833.28 | 30,679,975.05 |
| 财务费用 | 3,040,336.05 | -2,961,781.29 | -4,198,078.76 | -3,933,962.04 |
| 其中:利息费用 | 56,923.68 | 300,075.96 | 267,626.67 | 181,842.64 |
| 其中:利息收入 | 883,823.71 | 4,062,066.25 | 3,375,213.61 | 1,999,931.06 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,771,448.11 | 7,528,763.66 | 5,576,400 | 3,691,138.89 |
| 加:投资收益 | 22,533,771.54 | 7,860,780.25 | 5,752,496.14 | 4,712,123.65 |
| 资产处置收益 | -49,164.17 | 712,121.36 | 712,121.36 | 726,244.5 |
| 资产减值损失(新) | -600,600.72 | -3,390,007.88 | -2,615,676.27 | -1,755,819.94 |
| 信用减值损失(新) | -667,813.14 | -1,213,967.77 | -1,310,636.3 | -49,376.36 |
| 其他收益 | 2,168,815.27 | 13,817,066.72 | 8,391,284.05 | 5,757,847.08 |
| 四、营业利润 | 29,125,982.6 | 53,483,542.82 | 44,252,006.36 | 34,970,701.61 |
| 加:营业外收入 | - | 36,394.14 | 9,347.02 | 9,227.03 |
| 减:营业外支出 | -886.2 | 2,177,048.41 | 2,163,300 | 2,163,300 |
| 五、利润总额 | 29,126,868.8 | 51,342,888.55 | 42,098,053.38 | 32,816,628.64 |
| 减:所得税费用 | 42,162.59 | 260,588.31 | 177,495.24 | 148,501.38 |
| 六、净利润 | 29,084,706.21 | 51,082,300.24 | 41,920,558.14 | 32,668,127.26 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 29,084,706.21 | 51,082,300.24 | 41,920,558.14 | 32,668,127.26 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 29,084,706.21 | 51,082,300.24 | 41,920,558.14 | 32,668,127.26 |
| 扣除非经常损益后的净利润 | 2,298,227.68 | 23,588,628.16 | 24,066,000.8 | 20,806,323.47 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.06 | 0.11 | 0.09 | 0.07 |
| (二)稀释每股收益 | 0.06 | 0.11 | 0.09 | 0.07 |
| 八、其他综合收益 | -8,526,714.75 | 5,041,778.7 | 4,045,296.27 | -18,494.87 |
| 归属于母公司股东的其他综合收益 | -8,526,714.75 | 5,041,778.7 | 4,045,296.27 | -18,494.87 |
| 九、综合收益总额 | 20,557,991.46 | 56,124,078.94 | 45,965,854.41 | 32,649,632.39 |
| 归属于母公司股东的综合收益总额 | 20,557,991.46 | 56,124,078.94 | 45,965,854.41 | 32,649,632.39 |
| 公告日期 | 2026-04-30 | 2026-03-31 | 2025-10-28 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |